n******n
发帖数: 12088 | 1 MEMC Electronic Materials (WFR) shares are coming under pressure this
morning after Hapoalim Securities analyst Gordon Johnson cut his rating on
the stock to Sell from Hold.
He contends the Street is over-estimating the first half profitability for
the maker of silicon wafers; in particular he thinks his fellow analysts are
“grossly over-estimating” margin leverage in the company’s SunEdison
solar projects business. He also thinks the Street is too optimistic on
growth in the company’s semicon |
|
|
c******i
发帖数: 4091 | 3 Dump Romney; Nominate Paul
August 07, 2012 AFP
Dump Romney; Nominate Ron Paul
By Michael Collins Piper
Because there are real doubts that presumed GOP nominee Mitt Romney has what
it takes to displace the current White House occupant in the general
election, there are some Republicans who have a message for the delegates to
the forthcoming GOP National Convention: Dump Romney and nominate Rep. Ron
Paul (R-Texas).
In stark contrast to outspoken populist Paul, whose integrity is undoubted,
whose... 阅读全帖 |
|
m********0
发帖数: 2717 | 4 disagree. I don't think underwriter has a lot to do with performance.
Underwriter Rank Mkt Share(%) Amount USD (Mln) Fees(%) Issues
JP Morgan 1 12.6 216,197.00 0.433 907
Barclays Capital 2 11.9 204,707.86 0.195 673
Bank of America Merrill Lynch 3 10 171,429.20 0.518 1,013
Deutsche Bank AG 4 8.3 143,158.03 0.317 587
Citi 5 8.1 139,097.05 0.444 833
UBS 6 7.2 123,350.21 0.223 448
Goldman Sachs &... 阅读全帖 |
|
r*******u
发帖数: 8732 | 5 蘋果股價首越300美元
市值全球次高 目標價最高$430
【明報專訊】下周一公布業績的蘋果(代號AAPL)，由於投資者看好iPad和其他產品銷售
前景，昨天股價首次突破300美元大關，也進一步站穩全球市值第二高位置，僅次於埃
克森美孚(代號XOM)。
蘋果今年升值四成 納指升7％
蘋果昨天開市後便突破300美元大關，一度升至301.96美元；收市回軟至300.14美元，
但仍升1.6美元，總市值2,742億美元；今年來蘋果股價升逾四成，而納指同期只升約7
％。
蘋果市值上月曾逼近埃克森美孚，但由於近期油價反彈，惠及埃克森美孚股價；昨收報
65.04美元，升0.34美元，市值3,311.7億美元。
法國興業銀行分析員Andy Perkins認為，蘋果股價持續升，主要因為iPad和iPhone 4
持續受歡迎。
市場也廣泛預期，除了AT&T(代號T)作為iPhone美國獨家代理外，蘋果明年會同時把
iPhone交予Verizon Wirelss(代號VZ)代理，以擴大美國的銷售網絡。
即使蘋果股價最近急升，但很多研究蘋果的分析員仍認為蘋果股價可以更上一層樓，因
為它的股價仍低於大部分分析員... 阅读全帖 |
|
B****a
发帖数: 1526 | 6 http://finance.yahoo.com/news/Teva-to-buy-Cephalon-for-68-rb-55
On Monday May 2, 2011, 8:48 am EDT
By Lewis Krauskopf
NEW YORK (Reuters) - Teva Pharmaceutical Industries Ltd struck a deal to
acquire U.S. specialty drugmaker Cephalon Inc (NasdaqGS:CEPH - News) for
nearly $7 billion, topping an unsolicited bid by Canada's Valeant
Pharmaceuticals International Inc and boosting its brand-name drug business.
Teva's (Tel Aviv:TEVA.TA - News; NasdaqGS:TEVA - News) $81.50-a-share deal
is a nearly 12 per... 阅读全帖 |
|
|
S***a
发帖数: 1072 | 8 September's BioPharma Catalyst Calendar
By Lisa LaMotta Sep 01, 2010 2:40 pm
This month could be full of opportunities for biotech and pharmaceutical
investors who know where to look.
•More by Lisa LaMotta
•Forest Faces a Positive-Leaning PanelOrexigen Fattens Its Coffers
With Takeda CashSeptember's BioPharma Catalyst CalendarWhat's the Buzz?
30 top traders on these stocks and more
VVUS 6.33 +0.61 (+10.75%)
FRX 29.20 +1.55 (+5.61%)
CBST 22.52 -0.09 (-0.40%)
... 阅读全帖 |
|
